Sarah Cross

Sarah Cross is a Group Director of Study Operations at AstraZeneca. She is responsible for the planning and implementation of all operational aspects of early phase oncology clinical trials. She has over 15 years of experience in the pharmaceutical industry, and has held various leadership positions in clinical operations. She is a graduate of the University of Oxford, and holds a Master's degree in Clinical Trials.